Article - 02/03/2017 Personalised antibiotics therapy: fewer antibiotic-resistant bacteria Antibiotics have long been used as all-purpose weapons against infectious diseases – too often and too early, as we now know. This tendency has caused many bacteria to become resistant to standard antibiotics. The search for new substance classes has proved quite difficult. Care must therefore be taken to use existing antibiotics prudently in order to reduce the number of bacteria becoming resistant to them in the long term. Researchers from…https://www.gesundheitsindustrie-bw.de/en/article/news/personalised-antibiotics-therapy-fewer-antibiotic-resistant-bacteria
Article - 28/08/2017 SpinDiag GmbH – rapid test makes it difficult for pathogens Antibiotic-resistant pathogens are becoming an increasing problem, especially in hospitals. Infected patients must be isolated as soon as possible. However, appropriate methods for testing patients upon admission to hospital and isolating them if necessary are still lacking. A young biotechnology company from Baden-Württemberg called SpinDiag GmbH has developed a cost-effective method for the rapid testing of microbial resistance in normal…https://www.gesundheitsindustrie-bw.de/en/article/news/spindiag-gmbh-rapid-test-makes-it-difficult-for-pathogens
Freiburg im Breisgau - 04/06/2019 Spindiag’s continued road to success: Expansion of Series A with an additional 4 million euros for market entry Spindiag, a young medtech company in the German state of Baden-Württemberg, announced today the expanded financing of its first Series A. Based on a proprietary microfluidic technology first researched at the company’s mother institute Hahn-Schickard, Spindiag is developing a sustainable platform to diagnose infections and, as a first product, a rapid test for multidrug-resistant bacteria.https://www.gesundheitsindustrie-bw.de/en/article/press-release/spindiags-continued-road-to-success-expansion-of-series-a-with-an-additional-4-million-euros-for-market-entry
Article - 07/04/2008 Bacteriophages fighting against wound infections The increasing number of bacteria that are resistant to antibiotics is becoming a great problem in the treatment of infected wounds. The Hohenstein Institutes are developing novel wound dressings that use bacteriophages to combat even the most virulent pathogens.https://www.gesundheitsindustrie-bw.de/en/article/news/bacteriophages-fighting-against-wound-infections
Article - 30/07/2012 How to prevent pathogens from developing antibiotic resistances For bacteria, the environment is rather like a big market where they can give and receive new survival strategies if need be. A group of researchers led by Prof. Dr. Elisabeth Grohmann at the Freiburg University Medical Centre is investigating how microorganisms exchange antibiotic resistance genes. In a project involving two hospitals in Mexico City, the molecular biologists are also investigating whether pathogens, resistance genes and…https://www.gesundheitsindustrie-bw.de/en/article/news/how-to-prevent-pathogens-from-developing-antibiotic-resistances
Article - 09/03/2008 Successful attack on resistant tumour cells In laboratory experiments Dr. Anja Apel from the University Hospital in Heidelberg proved that cancer cells that are resistant to radiation therapy can be made to become susceptible to this kind of treatment again by blocking the cells own recycling system.https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-attack-on-resistant-tumour-cells
Press release - 24/05/2010 University of Stuttgart – biopolymers as construction material of the future? The Institute of Building Structures and Structural Design (ITKE) at the University of Stuttgart is investigating whether it is possible to replace traditional plastics in the building industry with natural fibre-reinforced biopolymers. As part of the project, which is being funded by the Deutsche Bundesstiftung Umwelt, the ITKE researchers are working with the Nimbus Group to develop transparent lightweight building boards from biopolymers with…https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-of-stuttgart-biopolymers-as-construction-material-of-the-future
Press release - 14/06/2010 Substance in broccoli supports pancreatic cancer therapy The new cancer medication sorafenib inhibits resistant tumour stem cells in pancreatic cancer and is especially effective when combined with sulforaphane, an organic compound found in broccoli and cauliflower.https://www.gesundheitsindustrie-bw.de/en/article/press-release/substance-in-broccoli-supports-pancreatic-cancer-therapy
Press release - 03/12/2018 SpinDiag closes second financing round of EUR 3.0 million (USD 3.4 million) to complete product development of its point-of-care screening system for antibiotic-resistant bacteria One year after its seed financing, SpinDiag GmbH closes a second financing round of EUR 3 million (USD 3.4 million) as planned. The financing will enable SpinDiag to complete the product development of its first product for screening for antibiotic-resistant bacteria and to start clinical trials. This will pave the way for regulatory approval in the EU.https://www.gesundheitsindustrie-bw.de/en/article/press-release/spindiag-closes-second-financing-round-of-eur-30-million-usd-34-million-to-complete-product-development-of-its-point-of-care-scr
Article - 19/09/2011 k-labor GmbH – a specialist in material analysis and characterisation k-labor GmbH focuses on the initial inspection of samples for the automotive industry and the testing of a broad range of different materials. k-labor also specialises in environmental simulations and durability testing and offers consulting and the transfer of technologies in the plastics sector. https://www.gesundheitsindustrie-bw.de/en/article/news/k-labor-gmbh-a-specialist-in-material-analysis-and-characterisation
Article - 22/04/2014 Sugar code and hygiene in the fight against multi-resistant pathogens Horizontal gene transfer between bacteria is a major reason for the spread of bacterial antibiotic resistance. It is the transfer of bacterial DNA from one bacterium to another, even distantly related species, by bacteriophages, viruses that infect bacteria. Microbiologists from the University of Tübingen are investigating these mechanisms with the aim of finding new strategies that would effectively combat bacteria such as methicillin-resistant…https://www.gesundheitsindustrie-bw.de/en/article/news/sugar-code-and-hygiene-in-the-fight-against-multi-resistant-pathogens
Article - 17/02/2014 Soil bacteria explored as source of new antibiotics Two scientists from the Interfaculty Institute of Microbiology and Infection Medicine IMIT at the University of Tübingen PD Dr. Evi Stegmann and Dr. Yvonne Mast are exploring the biosynthesis of antibiotic substances with the aim of modifying them to make them suitable for application in the fight against multidrug-resistant bacteria.https://www.gesundheitsindustrie-bw.de/en/article/news/soil-bacteria-explored-as-source-of-new-antibiotics
Press release - 21/07/2008 Ulm awards adiposity researcher Martin Wabitsch has received the Science Award of the city of Ulm. Wabitsch head of Paediatric Endocrinology and Diabetes at the University Hospital of Ulm received the award for his research on the consequences of adipositas at a young age.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulm-awards-adiposity-researcher
Article - 26/09/2008 University Hospital of Ulm combines forces The Comprehensive Infectious Diseases Centre at the University of Ulm was recently presented to the public. The centre is responsible for coordinating the cooperation between specialists in the diagnosis and therapy of complex infectious diseases.https://www.gesundheitsindustrie-bw.de/en/article/news/university-hospital-of-ulm-combines-forces
Dossier - 04/07/2011 Implants of the future: bioactive, corrosion-resistant and antibacterial People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
Article - 11/12/2017 KDM4 – an efficient target for the therapy of triple-negative breast cancer While breast cancer survival has clearly improved in recent years, women with triple-negative breast cancer have benefitted very little from progress in cancer medicine. Targeted therapies aimed at inhibiting epigenetic regulators might offer a potential new option for the treatment of breast cancer. Prof. Dr. Roland Schüle and Dr. Jochen Maurer have discovered an epigenetic enzyme called KDM4 and come up with a new cell model that significantly…https://www.gesundheitsindustrie-bw.de/en/article/news/kdm4-an-efficient-target-for-the-therapy-of-triple-negative-breast-cancer
Article - 17/10/2010 A high-tech strategy to become a reference laboratory The Konstanz-based Labor Dr. Brunner is the first medical laboratory in Germany to use a worldwide revolutionary instrument for liquid sample processing in bacteriological laboratories. The Walk-Away Specimen Processor (WASP) is a faster and more reliable processor that automatically identifies resistant pathogens such as MRSA or ESBL-type bacteria that have become part of the growing number of antibiotic-resistant pathogens that cause…https://www.gesundheitsindustrie-bw.de/en/article/news/a-high-tech-strategy-to-become-a-reference-laboratory
Article - 16/01/2012 Alexander Titz: molecular design to combat antibiotic-resistant bacteria Pseudomonas aeruginosa has become an important cause of infection, and is often picked up in hospitals, especially by patients with weakened immune systems. It can cause respiratory and urinary tract infections, as well as lead to infections on implants and wounds. P. aeruginosa lives in a gel-like matrix, a so-called biofilm that is highly resistant to antibiotics, making it very difficult to eradicate. Dr. Alexander Titz and his team at the…https://www.gesundheitsindustrie-bw.de/en/article/news/alexander-titz-molecular-design-to-combat-antibiotic-resistant-bacteria
Press release - 17/08/2008 Methadone kills leukaemia cells Claudia Friesen and her team of researchers from Ulm University discovered that methadone an agent used as a replacement-opiate in heroin addicts is able to kill leukaemia cells that are resistant to chemotherapy and radiation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/methadone-kills-leukaemia-cells
Press release - 23/12/2009 The spread of HIV: optimal adaptation to the human host A new study led by the virologist and Leibniz Award winner Frank Kirchhoff from Ulm might be about to provide an explanation as to why only one of several independent transmissions of simian immunodeficiency viruses (SIV) from chimpanzees to humans led to the global AIDS pandemic. The researchers now hope that these new findings will contribute to the search for new strategies to prevent the further spread of AIDS viruses.https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-spread-of-hiv-optimal-adaptation-to-the-human-host
Press release - 12/10/2009 Methadone for treating brain tumours - finally an effective therapy in sight? Every year, around 5,500 people in Germany are diagnosed with malignant brain tumours. The chances of effectively treating patients with such tumours have barely improved over the last decades. A new therapeutic appears to be promising. Scientists at the Institute of Forensic Medicine at the University Hospital of Ulm have been able to show that methadone has the ability to combat brain tumours.https://www.gesundheitsindustrie-bw.de/en/article/press-release/methadone-for-treating-brain-tumours-finally-an-effective-therapy-in-sight
Article - 16/12/2009 BioValley “Science meets Business Day 2009” This year’s presentations at the “Science meets Business Day 2009” once again showed that the exchange between science and the industry in the BioValley works extraordinarily well. The “Science meets Business Day 2009” concluded this year’s BioValley Life Science Week, where researchers from five completely different disciplines and their industrial partners presented their views on what makes the economic location in the area bordered by…https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-science-meets-business-day-2009
Article - 20/02/2018 New strategies against malaria Malaria, which is a mosquito-borne disease caused by Plasmodium parasites, is still one of the worst infectious human diseases. The parasites have developed resistance against previously effective drugs and new strategies to combat malaria are urgently needed.https://www.gesundheitsindustrie-bw.de/en/article/news/new-strategies-against-malaria
Article - 28/04/2014 New ways to interfere with bacterial strategies Bacteria themselves provide the key to their destruction. New insights into the growth and interaction between different pathogens are used in microbial genetics to develop new methods and active substances for combatting multidrug-resistant bacterial strains.https://www.gesundheitsindustrie-bw.de/en/article/news/new-ways-to-interfere-with-bacterial-strategies
Press release - 10/12/2018 High distinction for stem cell researcher Andreas Trumpp This year's State Research Prize of Baden-Württemberg awarded for outstanding achievements in applied research goes to Andreas Trumpp from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM). Theresia Bauer, State Minister of Science, Research and the Arts, presented the award, which carries a monetary prize of €100.000, at a festive ceremony on December 10, 2018.https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-distinction-for-stem-cell-researcher-andreas-trumpp